AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Adam H Skeens

Appears inactive Last observed office action: March 2024 (24 months ago).

Examiner Adam H Skeens appears to be about average relative to their peer examiners. Their lifetime grant ratio is 28.6%, they average 1.00 office actions per granted patent, and their rejection profile leans toward §103 and occasional §101 rejections.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.00
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
2 years (2023-2024)
Tech Center
1600 - Biotechnology and Organic
Group
1640 - Immunology

Metrics

Applications Evaluated
7
Granted Applications
2
Non-Granted Applications
5
Avg OA / Grant
1.00
Last OA Observed
March 2024 (24 months ago)
Art Units Seen
1647
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 28.6% 1.00
Art Unit 36 42.6% 1.60
Group 223 44.8% 1.94
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2023 2024
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2023; examiner may not yet have been active in the available dataset.
2023 4 2 50.0%
2024 3 0 0.0%
No observed data after 2024; examiner may have gone inactive or moved out of examining work.

2 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 11 0.0% 0.0% 36.4% 0.0%
2 3 33.3% 0.0% 66.7% 0.0%

§ 101 Yearly Trend

0.0%
2023
12.5%
2024

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.